NVCR Stock Up as TTFields Therapy Meets Pancreatic Cancer Study Goals

Published on 3 Dec 2024 on Zacks · via Yahoo Finance

Novocure stock soars 49% as the late-stage study of TTFields therapy for treating pancreatic...

Read the rest of the article

Start tracking your investments with Statfolio

The life science industry recently gave folks diagnosed with pancreatic cancer the best news this...

Motley Fool · via Yahoo Finance 5 Dec 2024

The deal centers on a drug called PTC518, which uses splicing technology to control how proteins ...

Investor's Business Daily 3 Dec 2024

On Monday, NovoCure Ltd (NASDAQ:NVCR) and Zai Lab Limited (NASDAQ:ZLAB) revealed topline data fro...

Benzinga · via AOL 3 Dec 2024

Novocure stock soars 49% as the late-stage study of TTFields therapy for treating pancreatic...

Zacks · via Yahoo Finance 3 Dec 2024

U.S. stocks were mixed, with the Dow Jones index falling more than 100 points on Monday. Shares o...

Benzinga 2 Dec 2024

Add to that a 22% jump in third-quarter revenues and FDA approvals for cutting-edge products like...

GuruFocus.com · via Yahoo Finance 2 Dec 2024

If you’re wondering what stocks to buy this month, look no further. Every investor wants their st...

InvestorPlace via Yahoo Finance 15 May 2024

NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript May 2, 2024 NovoCure Limited beat...

Insider Monkey via Yahoo Finance 3 May 2024

Organon & Co. OGN is scheduled to release first-quarter 2024 results on May 2, before the opening...

Zacks via Yahoo Finance 1 May 2024

In this article, we will take a look at aggressive stock portfolio: 13 stocks picked by analysts....

Insider Monkey via Yahoo Finance 5 Apr 2024